BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16353114)

  • 1. Implant infections due to enterococci: role of capsular polysaccharides and biofilm.
    Fabretti F; Huebner J
    Int J Artif Organs; 2005 Nov; 28(11):1079-90. PubMed ID: 16353114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of implant infections by enterococci.
    Baldassarri L; Creti R; Montanaro L; Orefici G; Arciola CR
    Int J Artif Organs; 2005 Nov; 28(11):1101-9. PubMed ID: 16353116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
    Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
    Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the development of immunotherapy regimens against enterococcal infections.
    Theilacker C; Krueger WA; Kropec A; Huebner J
    Vaccine; 2004 Dec; 22 Suppl 1():S31-8. PubMed ID: 15576199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm in implant infections: its production and regulation.
    Costerton JW; Montanaro L; Arciola CR
    Int J Artif Organs; 2005 Nov; 28(11):1062-8. PubMed ID: 16353112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm formation capability of enterococcal strains causing urinary tract infection vis-a-vis colonisation and correlation with enterococcal surface protein gene.
    Garg S; Mohan B; Taneja N
    Indian J Med Microbiol; 2017; 35(1):48-52. PubMed ID: 28303818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and Prospects in Vaccine Development against Enterococci.
    Kalfopoulou E; Huebner J
    Cells; 2020 Nov; 9(11):. PubMed ID: 33147722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing future treatment of enterococcal infections: attacking the biofilm?
    Paganelli FL; Willems RJ; Leavis HL
    Trends Microbiol; 2012 Jan; 20(1):40-9. PubMed ID: 22169461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the specific immune response against capsular polysaccharides of two patients with systemic enterococcal infections.
    Hufnagel M; Huebner J
    Infection; 2005 Oct; 33(5-6):373-6. PubMed ID: 16258870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenicity of Enterococci].
    Ike Y
    Nihon Saikingaku Zasshi; 2017; 72(2):189-211. PubMed ID: 28659548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance in
    Torres C; Alonso CA; Ruiz-Ripa L; León-Sampedro R; Del Campo R; Coque TM
    Microbiol Spectr; 2018 Jul; 6(4):. PubMed ID: 30051804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm-associated infection by enterococci.
    Ch'ng JH; Chong KKL; Lam LN; Wong JJ; Kline KA
    Nat Rev Microbiol; 2019 Jan; 17(2):82-94. PubMed ID: 30337708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of unusual species of enterococci causing infections, South India.
    Prakash VP; Rao SR; Parija SC
    BMC Infect Dis; 2005 Mar; 5():14. PubMed ID: 15774018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistant enterococci-tales of a drug resistance gene trafficker.
    Werner G; Coque TM; Franz CM; Grohmann E; Hegstad K; Jensen L; van Schaik W; Weaver K
    Int J Med Microbiol; 2013 Aug; 303(6-7):360-79. PubMed ID: 23602510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: in vitro study.
    Zelichenko G; Steinberg D; Lorber G; Friedman M; Zaks B; Lavy E; Hidas G; Landau EH; Gofrit ON; Pode D; Duvdevani M
    J Endourol; 2013 Mar; 27(3):333-7. PubMed ID: 22970837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating implant infections. Remarks by a women's team.
    Arciola CR; Balaban N; Baldassarri L; Fromm K; Hansch GM; Obst U; Presterl E; Stefani S; Verran J; Visai L
    Int J Artif Organs; 2008 Sep; 31(9):858-64. PubMed ID: 18924099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combatting resistant enterococcal infections: a pharmacotherapy review.
    Mercuro NJ; Davis SL; Zervos MJ; Herc ES
    Expert Opin Pharmacother; 2018 Jun; 19(9):979-992. PubMed ID: 29877755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
    Lam S; Singer C; Tucci V; Morthland VH; Pfaller MA; Isenberg HD
    Am J Infect Control; 1995 Jun; 23(3):170-80. PubMed ID: 7677262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.